Bm. Derooij et al., URINARY METABOLITE PROFILE OF PHENYL AND O-CRESYL GLYCIDYL ETHER IN RATS - IDENTIFICATION OF A NOVEL PATHWAY LEADING TO N-ACETYLSERINE O-CONJUGATES, Chemical research in toxicology, 11(2), 1998, pp. 111-118
The urinary excretion of metabolites of phenyl glycidyl ether (PGE) an
d o-cresyl glycidyl ether (o-CGE) was investigated in rats. Urine was
collected, in fractions, from rats intraperitoneally administered PGE
or o-CGE in doses ranging from 0.033 to 1.0 mmol/kg. The metabolites w
ere extracted from acidified urine with ethyl acetate or diethyl ether
, and their identity was elucidated by GC/MS analysis. The epoxide of
PGE can be inactivated by glutathione (GSH) conjugation or epoxide hyd
rolysis. After further metabolism, these routes lead to the urinary ex
cretion of phenyl glycidyl ether mercapturic acid (PGEMA) and 3-(pheny
loxy)lactic acid (POLA). The excretion of PGEMA and POLA was described
before and is confirmed in this study. Additionally, a new metabolite
was identified as N-acetyl-O-phenylserine (NAPS), which is proposed t
o be formed from POLA by subsequent oxidation, transamination, and N-a
cetylation. For PGEMA a linear dose-excretion relationship was found (
r(2) = 0.988), and the percentage of the dose excreted declined from 2
7 % to 10 % with increasing PGE dose. For NAPS also a linear dose-excr
etion relationship was found (r(2) = 0.985), and NAPS accounted for 27
% of the PGE dose. The excretion of PGEMA and NAPS was rather fast: 9
3 % and 75 %, respectively, of the respective total cumulative amounts
excreted was already collected within 6 h after administration. The u
rinary metabolite profile of o-CGE was not investigated in rats before
. Three urinary metabolites of o-CGE were identified, namely, 3-(o-cre
syloxy)lactic acid (COLA), o-cresyl glycidyl ether mercapturic acid (o
-CGEMA), and N-acetyl-O-(o-cresyl)serine (NAGS), showing that the meta
bolite profiles of PGE and o-CGE are comparable. Up to a o-CGE dose of
0.333 mmol/kg, the excretion of o-CGEMA was linear (r(2) = 0.997), wh
ile above this dose the excretion did not increase anymore. The percen
tage of the o-CGE dose excreted as o-CGEMA declined from 31 % to 11 %
with increasing dose. Again 93 % of the total cumulative amount of o-C
GEMA excreted was collected within 6 h after administration of o-CGE.
Analytical methods were developed for the quantitative determination o
f mercapturic acid metabolites of PGE and o-CGE. These methods were su
fficiently sensitive for their determination in urine of rats administ
ered PGE or o-CGE in the dose range applied. It is anticipated that th
e analytical methods developed are also sufficiently sensitive to inve
stigate excretion of the mercapturic acid metabolites in humans occupa
tionally exposed to low air concentrations (< 6 mg/m(3) of air, 8h-TWA
) of PGE or o-CGE.